NAIO Trademark

Software-as-a-medical device (SaMD), downloadable, for medical research and development; Software-as-a-medical device (SaMD), downloadable, for use in clinical trials; Software-as-a-medical device (SaMD), downloadable, for medical diagnostic decision making in the field of central nervous system disorders; Software-as-a-medical device (SaMD), downloadable, for medical prognostic decision making in the field of central nervous system disorders; Software-as-a-medical device (SaMD), downloadable, for analyzing medical treatment data for assisting healthcare workers with predictive decision making for the medical treatment of persons in the field of central nervous system disorders; Software-as-a-medical device (SaMD), downloadable, for monitoring the status of a central nervous system medical condition; Software-as-a-medical device (SaMD), downloadable, for monitoring the safety of a therapeutic treatment for central nervous system disorders; Software-as-a-medical device (SaMD), downloadable, for evaluating the efficacy of a therapeutic treatment for central nervous system disorders; Software-as-a-medical device (SaMD), downloadable, for evaluating a pharmacodynamic biomarker for diagnostic purposes; Software-as-a-medical device (SaMD), downloadable, for evaluating a surrogate endpoint or reasonably likely surrogate endpoint in medical clinical trials; Software-as-a-medical device (SaMD), downloadable, for evaluating the risk of developing a disorder of the central nervous system; software-as-a-medical device (SaMD), downloadable, for prevention of disorders of the central nervous system

Software as a service (SaaS) services featuring software for medical research and development; Software as a service (SaaS) services featuring software for implementation of clinical trials; Software as a service (SaaS) services featuring software for assisting health care workers in medical diagnostic decision making in the field of central nervous system disorders; Software as a service (SaaS) services featuring software for assisting health care workers in medical prognostic decision making in the field of central nervous system disorders; Software as a service (SaaS) services featuring software for analyzing real time treatment data for assisting healthcare workers with predictive decision making for the medical treatment of persons; Software as a service (SaaS) services featuring software for monitoring the status of a medical condition; Software as a service (SaaS) services featuring software for monitoring the safety of a therapeutic treatment; Software as a service (SaaS) services featuring software for evaluating the efficacy of a therapeutic treatment; Software as a service (SaaS) services featuring software for evaluating a pharmacodynamic biomarker for diagnostic purposes; Software as a service (SaaS) services featuring software for evaluating data being a surrogate endpoint or reasonably likely surrogate endpoint in medical clinical trials; Software as a service (SaaS) services featuring software for evaluating the risk of developing a disorder of the central nervous system; Software as a service (SaaS) services featuring software for recommending treatments for the prevention of disorders of the central nervous system; Software as a service (SaaS) services featuring software for processing, managing, displaying and transmitting images of the central nervous system; Software as a service (SaaS) services featuring software for dissemination of test results and data analyses in the field of medical research, medical development, clinical trials, medical diagnostic decision making processes, medical prognostic decision making processes, predictive medical treatment decision making processes, monitoring the status of medical conditions, monitoring the safety of a therapeutic radiological service, evaluating pharmacodynamic biomarkers for diagnostic purposes, evaluating data to determine a surrogate endpoint in medical clinical trials, evaluating the risk of developing a disorder in the central nervous system, recommending treatments for the prevention of disorders of the central nervous system, and for processing, managing, displaying, and transmitting images of the central nervous system; Cloud computing featuring software for computing scientific data in the fields of medical research and development; Cloud computing featuring software for computing scientific data in the fields of clinical trials; Cloud computing featuring software for computing scientific data in the fields of medical diagnostic decision making; Cloud computing featuring software for computing scientific data in the fields of medical prognostic decision making; Cloud computing featuring software for computing scientific data in the fields of analyzing real time treatment data for assisting healthcare workers with predictive decision making for the medical treatment of persons; Cloud computing featuring software for computing scientific data in the fields of monitoring the status of a medical condition; Cloud computing featuring software for computing scientific data in the fields of monitoring the safety of a therapeutic treatment; Cloud computing featuring software for computing scientific data in the fields of evaluating the efficacy of a therapeutic treatment; Cloud computing featuring software for computing scientific data in the fields of evaluating a pharmacodynamic biomarker for diagnostic purposes; Cloud computing featuring software for computing scientific data in the fields of evaluating a surrogate endpoint or reasonably likely surrogate endpoint in clinical medical trials; Cloud computing featuring software for computing scientific data in the fields of evaluating the risk of developing a disorder of the central nervous system; Cloud computing featuring software for computing scientific data in the fields of prevention of disorders of the central nervous system; Cloud computing featuring software for computing scientific data in the fields of processing, managing, displaying and transmitting images of the central nervous system; Cloud computing featuring software for computing scientific data and disseminating the results and analyses in the field of medical research, medical development, clinical trials, medical diagnostic decision making processes medical prognostic decision making processes, predictive medical treatment decision making processes, monitoring the status of medical conditions, monitoring the safety of a therapeutic radiological service, evaluating pharmacodynamic biomarkers for diagnostic purposes, evaluating data to determine a surrogate endpoint in medical clinical trials, evaluating the risk of developing a disorder in the central nervous system, recommending treatments for the prevention of disorders of the central nervous system, and for processing, managing, displaying, and transmitting images of the central nervous system; Computer services, namely, providing a website featuring technology that enables users to share and process data for use in the fields of medical research and development; Computer services, namely, providing a website featuring technology that enables users to share and process data for use in the fields of clinical trials; Computer services, namely, providing a website featuring technology that enables users to share and process data for use in the fields of medical diagnostic decision making; Computer services, namely, providing a website featuring technology that enables users to share and process data for use in the fields of medical prognostic decision making; Computer services, namely, providing a website featuring technology that enables users to share and process data for use in the fields of medical treatment predictive decision making for the medical treatment of persons; Computer services, namely, providing a website featuring technology that enables users to share and process data for use in the fields of monitoring the status of a medical condition; Computer services, namely, providing a website featuring technology that enables users to share and process data for use in the fields of monitoring the safety of a therapeutic treatment; Computer services, namely, providing a website featuring technology that enables users to share and process data for use in the fields of evaluating the efficacy of a therapeutic treatment; Computer services, namely, providing a website featuring technology that enables users to share and process data for use in the fields of evaluating a pharmacodynamic biomarker for diagnostic purposes; Computer services, namely, providing a website featuring technology that enables users to share and process data for use in the fields of evaluating a surrogate endpoint or reasonably likely surrogate endpoint in medical clinical trials; Computer services, namely, providing a website featuring technology that enables users to share and process data for use in the fields of evaluating the risk of developing a disorder of the central nervous system; Computer services, namely, providing a website featuring technology that enables users to share and process data for use in the fields of prevention of disorders of the central nervous system; Consulting services for others in the field of design, planning, and implementation project management of medical research and medical research development; Consulting services for others in the field of design, planning, and implementation project management of clinical trials; Consulting services for others in the field of design, planning, and implementation project management of research in the field of medical diagnostic decision making; Consulting services for others in the field of design, planning, and implementation project management of research in the field of medical prognostic decision making; Consulting services for others in the field of design, planning, and implementation project management of research in the field of medical treatment and scientific data analysis for predictive clinical decision making projects; Consulting services for others in the field of design, planning, and implementation project management of medical research in the field of monitoring the status of a medical condition; Consulting services for others in the field of design, planning, and implementation project management of medical research in the field of monitoring the safety of a therapeutic treatment; Consulting services for others in the field of design, planning, and implementation project management of medical research in the field of evaluating the efficacy of a therapeutic treatment; Consulting services for others in the field of design, planning, and implementation project management of medical research in the field of evaluating a pharmacodynamic biomarker in clinical trials; Consulting services for others in the field of design, planning, and implementation project management of medical research in the field of evaluating a surrogate endpoint or reasonably likely surrogate endpoint in clinical trials; Consulting services for others in the field of design, planning, and implementation project management of medical research in the field of evaluating the risk of developing a disorder of the central nervous system; Consulting services for others in the field of design, planning, and implementation project management of medical research in the field of prevention of disorders of the central nervous system; Medical quality measurement analysis services for others in the field of monitoring the safety of a therapeutic products for medical practices; Medical analysis services for others in the field of medical research and medical preparation development; Research and development in the field of biotechnology with a focus on disorders of the central nervous system

Medical companion diagnostic services for medical development in the field of diagnosing central nervous system disorders; Medical companion diagnostic services for clinical trials; Medical companion diagnostic services for medical diagnostic decision making in the field of central nervous system disorders; Medical companion diagnostic services for medical prognostic decision making in the field of central nervous system disorders; Medical companion diagnostic services for treatment purposes to assist with predictive medical diagnostic decision making; Medical companion diagnostic services for monitoring the status of a medical condition; Medical companion diagnostic services for monitoring the safety of patients of a therapeutic treatment for medical diagnostic purposes; Medical companion diagnostic services for evaluating the efficacy of a therapeutic treatment in the nature of monitoring of data indicative of the health of an individual for medical diagnosis purposes; Medical companion diagnostic services for evaluating a pharmacodynamic biomarker for medical diagnostic purposes; Medical companion diagnostic services for evaluating a surrogate endpoint or reasonably likely surrogate endpoint in medical clinical trials; Medical companion diagnostic services for evaluating the risk of developing a disorder of the central nervous system; Medical companion diagnostic services for prevention of disorders of the central nervous system; Medical analysis services for others relating to the treatment of patients via medical clinical trials; Medical analysis services for others in the field of medical diagnostic decision making for the diagnosis of disorders of the central nervous system; Medical analysis services for other in the field of medical prognostic decision making for the medical treatment of persons with disorders of the central nervous system; Medical analysis services for other in the field of medical predictive decision making for the medical treatment of persons with disorders of the central nervous system; Medical analysis services for others in the field of monitoring the status of a medical condition in patients for diagnosis of central nervous system disorders in the human body; Medical analysis services for others in the field of monitoring the safety of a patient during therapeutic treatment for the purpose of diagnosing medical conditions; Medical analysis services for others in the field of evaluating the efficacy of a therapeutic treatment for the purpose of diagnosing medical conditions; Medical analysis services for others in the field of evaluating a pharmacodynamic biomarker in clinical medical trials for the purpose of diagnosing medical conditions; Medical analysis services for others in the field of evaluating a surrogate endpoint or reasonably likely surrogate endpoint in clinical medical trials for the purpose of diagnosing medical conditions; Medical analysis services for others in the field of evaluating the risk of developing a disorder of the central nervous system; Medical analysis services for others in the field of prevention of disorders of the central nervous system